Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Catalyst Pharmaceuticals (CPRX) Shares Repurchased (2016 - 2022)

Catalyst Pharmaceuticals (CPRX) has disclosed Shares Repurchased for 5 consecutive years, with $7000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Shares Repurchased fell 99.77% year-over-year to $7000.0, compared with a TTM value of $4.3 million through Mar 2023, down 70.27%, and an annual FY2025 reading of $25.3 million, changed N/A over the prior year.
  • Shares Repurchased was $7000.0 for Q4 2022 at Catalyst Pharmaceuticals, up from -$7000.0 in the prior quarter.
  • Across five years, Shares Repurchased topped out at $5.1 million in Q3 2021 and bottomed at -$7000.0 in Q3 2022.